Yongin, South Korea

Young-Jun Na

This inventor holds 1 USPTO granted patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young-Jun Na. Retrieved from https://idiyas.com/inventor/young-jun-na-qbfgogp9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young-Jun Na: Innovator in Cancer Treatment

Introduction

Young-Jun Na is a prominent inventor based in Yongin, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of serious diseases such as cancer.

Latest Patents

Young-Jun Na holds a patent for a "Compound of a reverse-turn mimetic and a production method and use therefor." This invention relates to novel compounds of reverse-turn mimetics, having pyrazino-triazinone as a basic framework. The method of preparing these compounds and their use in treating diseases, especially acute myeloid leukemia, showcases his innovative approach to addressing critical health challenges.

Career Highlights

He is currently associated with Jw Pharmaceutical Corporation, where he continues to work on groundbreaking research and development projects. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical industry.

Collaborations

Young-Jun Na collaborates with notable colleagues, including Young-Seok Cho and Yong-Sil Lee, to advance their research initiatives and enhance the impact of their inventions.

Conclusion

Young-Jun Na's work exemplifies the vital role of innovation in the fight against cancer. His contributions to the field are paving the way for new treatment options and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…